Response against salvage chemotherapies for the 36 patients who showed relapse or PD after rituximab-containing chemotherapies.
| Response . | CD20 expression . | ||
|---|---|---|---|
| − . | + . | N.D. . | |
| CR | 0 | 5 | 3 |
| PR | 0 | 1 | 3 |
| SD | 0 | 1 | 1 |
| RD/PD | 0 | 2 | 2 |
| Death | 5 | 5 | 8 |
| Total cases | 5 | 14 | 17 |
| Response . | CD20 expression . | ||
|---|---|---|---|
| − . | + . | N.D. . | |
| CR | 0 | 5 | 3 |
| PR | 0 | 1 | 3 |
| SD | 0 | 1 | 1 |
| RD/PD | 0 | 2 | 2 |
| Death | 5 | 5 | 8 |
| Total cases | 5 | 14 | 17 |
These outcomes were evaluated in July, 2007.
CR indicates complete remisson; PR, partial response; SD, stable disease; RD/PD, relapse/progression; and N.D., Not determined.